Biotech startup iLoF (intelligent Lab on Fiber), has secured c.$5m (£4.1m) to help develop its intelligent drug development platform. The funding includes $4m in equity investment led by Faber, with additional participation from M12 (formerly Microsoft Ventures), Quiet Capital, Lunar Ventures, Alter Venture Partners, re.Mind Capital, Fluxunit, and angel investors. The company also secured an €880k grant from the European Regional Development Fund. The latest investment takes total funding to date to over $8m.

Read more on TechMarketView here.